Skip to main content

Table 2 Relation between MDA and Sarnat scores shows that the mean MDA levels were 2.16 ± 0.31 μmol/l, 3.02 ± 0.67† μmol/l, and 4.13 ± 0.66†‡ μmol/l regarding Sarnat stages I, II, and III, respectively, in hypoxic neonates with highly statistical significant difference (P < 0.001)

From: Correlation between increased serum malondialdehyde and spectrum of cranial ultrasonography findings in hypoxic ischemic encephalopathy: could it be used as a predictor of disease severity?

Variable Sarnat stage I Sarnat stage II Sarnat stage III F df P value¶
MDA(nmol/ml) 2.16 ± 0.31 3.02 ± 0.67† 4.13 ± 0.66†‡ 39.491 2, 39 < 0.001
  1. Data are mean ± SD
  2. F F statistic, df Degree of freedom
  3. ¶One-way analysis of variance (ANOVA)
  4. P value < 0.05 vs. Sarnat stage I (Tukey-Kramer test)
  5. P value < 0.05 vs. Sarnat stage II (Tukey-Kramer test)